Paul Shotbolt

[Irene Faiman @IFaiman]

🔬 Excited to announce the culmination of 3 years of dedicated effort – our two #EEG studies are now out in @braincomms 🧠💡, tackling the challenge of differentiating between #epilepsy and #PNES.
Are we there yet? Find out! 👇@Paul_Shotbolt @IoPPN_NREG
https://t.co/RMoM8dpkEP

[Paul Shotbolt @Paul_Shotbolt]

As you know I'm very committed to neurotechnology and #Healthcare #innovation & I’m attending GIANT Health ’23 on 4-5 December, London. If you work in #health collect a free ticket & meet me there. Click here https://t.co/htTAwlDav4
#technology #GIANT2023

[Paul Shotbolt @Paul_Shotbolt]

Forthcoming #neurotechnology conference hosted by Innovate UK KTN - https://t.co/VTiUsw4CRZ

[Paul Shotbolt @Paul_Shotbolt]

Another original study from Irene Faiman; the first time risk factors for suicidality have been examined in people with dissociative seizures....

[Irene Faiman @IFaiman]

📢 Preprint Alert! 🧠 Our study is the first to systematically examine risk factors for suicidality in a large sample of people with functional/dissociative seizures. 📊🔍 #SuicidePrevention #FND @Paul_Shotbolt @IoPPN_NREG
🔗https://t.co/4BTmUe14X2

[IoPPN Neuropsychiatry Research & Education Group @IoPPN_NREG]

Great lecture from @IFaiman on important but poorly researched topic: suicidal ideation, acts & completion in epilepsy & functional seizures👏👏👏